Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Marksans Pharma Ltd.
NSE: MARKSANS
|
BSE: 524404
|
ISIN: INE750C01026
|
Industry: Pharmaceuticals
US FDA Approval
|
Mid-range Performer
168.1500
0.11
(
0.07
%)
NSE
Apr 02, 2026
15:31 PM
New 52W Low in past week
Volume:
550.7K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Marksans Pharma Ltd.
14 Apr 2015
US FDA Approval
168.15
0.07%
Marksans Pharma
Marksans Pharma Ltd.
by
ICICI Securities Limited
ICICI Securities Limited
Marksans Pharma Ltd. is trading below all available SMAs
More from Marksans Pharma Ltd.
Recommended
Five Interesting Stocks Today - April 2, 2026
The Baseline |
02 Apr 2026, 06:00PM
Market closes higher on strong rupee and value buying
Trendlyne Marketwatch |
02 Apr 2026, 03:59PM
Marksans Pharma facility receives four observations from US FDA
|
10 Apr 2017